Sonnet BioTherapeutic CVR
SONN.CVR----
Sonnet BioTherapeutic CVR (SONN.CVR)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- MorningStar · May 5 at 09:20 AM
Creatv Announces Five Clinical Data Presentations at ASCO 2026
- prnewswire · Mar 30 at 08:35 AM
09:35 ETHengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy
- Unusual Whales · Feb 5 at 07:03 AM
Braveheart Bio appoints Marc Evanchik as CSO and Brittany de Temple as SVP, advancing towards global Phase 3 trials.
